Zacks Investment Research on MSN
NTRA's Signatera secures PMDA approval for MRD testing in CRC in Japan
Natera NTRA recently announced that Signatera has received PMDA approval in Japan for use in colorectal cancer (CRC) patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results